Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold
Source: SeekingAlpha
2025-09-24 15:22:13 ET
Investment Overview
Earlier this year - on February 13th, to be precise, in a note for Seeking Alpha I switched my Sell rating on Acadia Pharmaceuticals Inc. ( ACAD ) stock to a Buy....
Read the full article on Seeking Alpha
For further details see:
Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold
ACADIA Pharmaceuticals Inc.
NASDAQ: ACAD
ACAD Trading
-1.34% G/L:
$21.025 Last:
573,736 Volume:
$21.41 Open:
ACAD Latest News
March 12, 2026 04:05:00 pm
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 09, 2026 09:54:00 am
Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment
March 03, 2026 04:05:00 pm
Acadia Pharmaceuticals Appoints Jonathan M. Poole to its Board of Directors
ACAD Stock Data
$3,864,112,700
124,348,635
0.05%
128
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
